Atopic Dermatitis

Charting New Course: The Frontier of Early Intervention and Disease Modification in AD

Early Intervention and Disease Modification in Atopic Dermatitis

Understanding Cumulative Disease Burden in Uncontrolled AD

This evidence-based 3.17-minute video explores how uncontrolled atopic dermatitis creates cumulative disease burden beyond visible skin manifestations. Discover the hidden burden—psychological, social, and systemic impacts often overlooked—and the long-term implications of chronic inflammation. Learn to recognize progression patterns and the critical importance of early intervention strategies.

Improving Quality of Life in Patients with Uncontrolled Atopic Dermatitis (AD): Tools for Timely Identification and Treatment

Unseen Burdens: How Cumulative Life Course Impairment (CLCI) Affects Patients with Moderate-to-Severe Atopic Dermatitis (AD)

The Hidden Impact of Cumulative Life Course Impairment (CLCI) in Dermatology: An Overview

Factors Associated with Development of Atopic Comorbidities in AD

The soundbite recording captures Dr. Paller's discussion on factors that contribute to the development of atopic comorbidities in patients with atopic dermatitis. The presentation examines the relationship between AD and associated atopic conditions.

Can Early Intervention Shape the Course of Atopic Dermatitis

The soundbite recording captures Dr. Paller's discussion examining whether early therapeutic intervention can influence the natural course of atopic dermatitis. The presentation explores the potential for timely treatment approaches to modify disease trajectory.

Impact of Advanced Systemic Therapies on Disease Control in AD

This educational video features Dr. Eric Simpson's presentation on the Impact of Advanced Systemic Therapies on Disease Control in AD

Disease Modification Concepts in Atopic Dermatitis

The soundbite recording captures Dr. Ramien's discussion of disease modification concepts in atopic dermatitis, exploring current understanding and approaches to altering disease progression.

Atopic Dermatitis in Children: High Burden and Limited Treatment Options

This educational video examines the prevalence of moderate and severe atopic dermatitis in children, presenting data that describes the significant disease burden and its impact on both pediatric patients and their families. The content explores current challenges in achieving optimal disease control in children with moderate and severe atopic dermatitis, providing healthcare professionals with evidence-based insights into the clinical management complexities of this patient population.

Association of Younger Age of Onset with Persistence of Atopic Dermatitis

The soundbite recording captures Dr. Paller's presentation examining the relationship between age of disease onset and AD persistence. The discussion explores how earlier onset of atopic dermatitis may influence disease trajectory and long-term outcomes in patients.

What Could Remission Mean in Atopic Dermatitis

The soundbite recording captures Dr. Simpson's discussion exploring the concept of remission in atopic dermatitis, examining what remission could mean in the context of AD management and patient outcomes.

Can Early Therapeutic Intervention Shape Disease Course in Pediatric AD

This approximately 3-minute clip focuses on the potential role of early therapeutic intervention in influencing the disease course of atopic dermatitis in children. The segment explores whether timely treatment approaches can modify disease trajectory in pediatric populations.

Type 2 Inflammation in Skin Tissue: Exploring Shared and Distinct Pathways in Prurigo Nodularis and Atopic Dermatitis

This educational video focuses on the role of type 2 inflammation in atopic dermatitis (AD) and prurigo nodularis (PN), examining how this inflammatory process contributes to cutaneous manifestations in both conditions.

AD and PN: Diagnosis and Impact on Quality of Life

Dr. Elmariah discusses atopic dermatitis and prurigo nodularis as distinct diseases that can coexist in some patients. The presentation addresses the diagnostic considerations and explores the multidimensional burden of both conditions on patients' quality of life.

The Cumulative Disease Burden of AD in Adult Patients

IL4 and IL13 important role in Chronic Itch

Long-Term-Impact-of-AD-and-the-Potential-benefits-of-early-intervention

The role of Epithelial Barrier Components in AD, insights and implications

About Type 2 Inflammation – Atopic Dermatitis

Atopic Dermatitis story

Patient Case – Dupilumab in Atopic Dermatitis

Atopic Dermatitis Pathophysiology: Breaking Down the Barrier